Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.13 AUD | -0.35% | +2.13% | +10.08% |
May. 22 | Jarden Downgrades ALS to Overweight From Buy, Adjusts Price Target to AU$14.90 From AU$13.70 | MT |
May. 21 | ALS Statutory Net Profit Plunges 96% in Fiscal 2024, Revenue Up 7%; Shares Rise 5% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.08% | 4.68B | |
+16.45% | 71.02B | |
+6.22% | 17.38B | |
+13.63% | 13.88B | |
+20.42% | 13.49B | |
+16.25% | 10.07B | |
-18.86% | 7.08B | |
-1.24% | 6.12B | |
+2.30% | 5.3B | |
+1.00% | 5.06B |
- Stock Market
- Equities
- ALQ Stock
- News ALS Limited
- ALS to Acquire Nuvisan; Shares Down 5%